🎯 check Zotatifin (eFT226) product page
Zotatifin (eFT226) is a potent eIF4A1 inhibitor. It affects JNK, NRF2, and E2F1 signaling pathways, and by inducing JNK phosphorylation and downregulating NRF2, it inhibits tumor proliferation and metastasis, and promotes apoptosis.